April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
Posters
Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials
April 7, 2025
More infoPosters
Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.
April 7, 2025
More infoBrochures & Infographics
Biomarker strategies to support success at every stage of therapy development
April 3, 2025
More info